Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice.
about
Production of a Chaetomium globosum enolase monoclonal antibodyExtracellular Vesicle-Associated Transitory Cell Wall Components and Their Impact on the Interaction of Fungi with Host CellsVaccine-mediated immune responses to experimental pulmonary Cryptococcus gattii infection in miceOral Immunization Against Candidiasis Using Lactobacillus casei Displaying Enolase 1 from Candida albicansCloning and Characterization of Surface-Localized α-Enolase of Streptococcus iniae, an Effective Protective Antigen in Mice.New approaches in the development of a vaccine for mucosal candidiasis: progress and challengesRecent progress in vaccines against fungal diseasesComparative Analysis of Cellular Immune Responses in Treated Leishmania Patients and Hamsters against Recombinant Th1 Stimulatory Proteins of Leishmania donovani.The impact of proteomics on the understanding of functions and biogenesis of fungal extracellular vesicles.Identification and characterization of Cryptococcus neoformans protein fractions that induce protective immune responsesDifferent virulence of candida albicans is attributed to the ability of escape from neutrophil extracellular traps by secretion of DNase.Immune modulators as adjuncts for the prevention and treatment of invasive fungal infections.Candida antigens and immune responses: implications for a vaccine.The Brucella melitensis M5-90 phosphoglucomutase (PGM) mutant is attenuated and confers protection against wild-type challenge in BALB/c mice.Assessment of Post-Vaccination Phagocytic Activation Using Candida albicans Killing Assays.Aspartic Proteases and Major Cell Wall Components in Candida albicans Trigger the Release of Neutrophil Extracellular Traps.RNAi-mediated silencing of enolase confirms its biological importance in Clonorchis sinensis.Cyclophilin and enolase are the most prevalent conidial antigens of Lomentospora prolificans recognized by healthy human salivary IgA and cross-react with Aspergillus fumigatus.Immunoproteomic analysis of antibody response to cell wall-associated proteins of Candida tropicalis.Identification of immunogenic proteins of Candida parapsilosis by serological proteome analysis.Brucella abortus phosphoglyceromutase and dihydrodipicolinate reductase induce Th1 and Th2-related immune responses.Antifungal activity of oral (Tragacanth/acrylic acid) Amphotericin B carrier for systemic candidiasis: in vitro and in vivo study.Outer Membrane Protein 25 of Brucella Activates Mitogen-Activated Protein Kinase Signal Pathway in Human Trophoblast Cells.Nonclassically secreted proteins as possible antigens for vaccine development: a reverse vaccinology approach.Recombinant Enolase of Trypanosoma cruzi as a Novel Vaccine Candidate against Chagas Disease in a Mouse Model of Acute Infection.
P2860
Q23910522-0CDDFD28-DEF6-4165-A2D0-43081FDC1E71Q26741582-E6B68700-27A4-4406-83AD-52A9D8817DA3Q28541882-E4EFC520-A5D1-42B6-817F-9C86D350785EQ35052906-0E164E0D-4396-4EAF-BCC1-BCCE6CC9368EQ35902402-57BE807D-98FE-4F39-805E-7BD7CC94D36AQ36158337-1919434D-35EC-47F7-ABF4-B335534F1D0CQ36179629-873D2B93-47DE-4A7D-9CFE-358D6C970490Q36712429-1800CCE6-6086-4B86-97C1-390487D72601Q37100258-F443A7E8-D69A-4A5D-A304-4C94679105ACQ37562226-FC54C2C3-D38D-4F3D-B9EB-DEFED8ABE62EQ37596861-95A4B599-8E15-4C7A-B981-0B300282A223Q38067451-BE9A3671-0DFC-4C3A-8493-ECC92A68EE83Q38222636-01ED36CD-1362-4DBE-9E91-083F83C53707Q38790245-57CED24D-FAD5-4B4E-B147-9567CEC6D857Q40183738-BE4CDF5A-7411-4A03-A3C9-4C615DBDC015Q42098852-6F7E68C1-7574-46AA-939E-CFCCDF97A5F5Q42231580-38268D62-8D7E-458D-9D27-BA25C9B3E460Q46506924-B3391465-FF88-4348-8D16-BB87D6C4E72FQ46882501-4CFDF5E4-E3EC-42EA-A627-E1D9BEAFD6F0Q46964249-7E041C85-EB40-437D-AC35-2E63E0737761Q47230639-0F8FCFC6-5FB3-4EE0-9872-F0173D7D3BACQ47245558-9BFA288C-2A3D-4A08-A92B-305D02ABC7B1Q49294287-16122D3E-42BB-47AE-8EAA-4761E6A1F874Q51009284-1F51F8CD-6B67-4B02-A5C4-A25C6EB68E4AQ55226818-91436D79-53C0-42C7-AE12-2306A2E55E85
P2860
Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Immunisation with the glycolyt ...... da albicans infection in mice.
@en
Immunisation with the glycolyt ...... da albicans infection in mice.
@nl
type
label
Immunisation with the glycolyt ...... da albicans infection in mice.
@en
Immunisation with the glycolyt ...... da albicans infection in mice.
@nl
prefLabel
Immunisation with the glycolyt ...... da albicans infection in mice.
@en
Immunisation with the glycolyt ...... da albicans infection in mice.
@nl
P2093
P1433
P1476
Immunisation with the glycolyt ...... da albicans infection in mice.
@en
P2093
Robert B Ashman
Sainan Zhao
Wen qing Li
Xiaohuan Zhang
Yanping Ge
P304
P356
10.1016/J.VACCINE.2011.05.030
P407
P577
2011-06-07T00:00:00Z